References
- Margetic' B, Margetic' BA. Neuroleptic malignant syndrome and its controversies. Pharmacoepidemiol Drug Saf 2010; 19(5): 429–35.
- Moscovich M, Nóvak FTM, Fernandes AF, Bruch T, Tomelin T, Nóvak EM, Munhoz RP, Teive HAG. Neuroleptic malignant syndrome. Arq Neuropsiquiatr 2011; 69(5): 751–5.
- Friedman LS, Weinrauch LA, D'Elia JA. Metoclopramide-induced neuroleptic malignant syndrome. Arch Intern Med 1987; 147(8): 1495–97.
- Pelonero A, Levenson J, Pandurangi A. Neuroleptic malignant syndrome: a review. Psychiatric Services 1998; 49(9): 1163–72.
- Gillman PK. Neuroleptic malignant syndrome: mechanisms, interactions, and causality. Mov Disord 2010; 25(12): 1780–90.
- Meterissian GB. Risperidon-induced neuroleptic malignant syndrome: A case report and review. Can J Psychiatr 1996; 41(1): 52–4.
- Berardi D, Dell'Atti M, Amore M, De Ronchi D, Ferrari G. Clinical risk factors for neuroleptic malignant syndrome. Hum Psychopharmacol 2002; 17(2): 99–102.
- Viejo LF, Morales V, Puñal P, Pérez JL, Sancho RA. Risk factors in neuroleptic malignant syndrome. A case-control study. Acta Psychiatr Scand. 2003; 107(1): 45–9.
- El-Gaaly S, St John P, Dunsmore S, Bolton JM. Atypical neuroleptic malignant syndrome with quetiapine: a case report and review of the literature. J Clin Psychopharmacol 2009; 29(5): 497–9.
- Solomons K. Quetiapine and neuroleptic malignant syndrome. Can J Psychiatry 2002; 47(8): 791.
- American Psychiatric Association. Medication-induced movement disorders: neuroleptic malignant syndrome. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. American Psychiatric Association: Washington D.C., 2000; 795–8.
- Chan LG, Lee J, Ng BT, Chua HC, Sim K. Rare neuropsychiatric sequelae following neuroleptic malignant syndrome: A case report and review of the literature. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32(8): 1998–9.
- Stanfield SC, Privette T. Neuroleptic malignant syndrome associated with olanzapine therapy: a case report. J Emerg Med 2000; 19(4): 355–7.
- Reulbach U, Dütsch C, Biermann T, Sperling W, Thuerauf N, Kornhuber J, Bleich S. Managing an effective treatment for neuroleptic malignant syndrome. Crit Care 2007; 11(1): 4.